Tel: +86-021-3762 1270
Fax: +86-021-6762 1877
Email: service@genicbio.com



| FC131 TFA | {2-Naph-Ala}-{Gly}-{Tyr}-{Arg}-{Arg} |
| (Arg)9 TFA | RRRRRRRRR |
| (Glp1)-Apelin-13, human, bovine | Glp-RPRLSHKGPMPF |
| (Met 210) Melanoctye Protein PMEL 17 (209-217) (human) | IMDQVPFSV |
| [Ala1,3,11,15]-Endothelin TFA | ASASSLMDKEAVYFAHLDIIW |
| [Ala9] Autocamtide 2 | KKALRRQEAVDAL |
| [Arg8]-Vasotocin TFA | Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH2(Disulfide bridge:Cys1-Cys6) |
| [Asp371]-Tyrosinase (369-377), human | YMDGTMSQV |
| [bAla8]-Neurokinin A(4-10) | DSFV-{Bal}-LM-NH2 |
| [Cys8] Renin Substrate Tetradecapeptide, rat | DRVYIHPCHLLYYS |
| [Des-Arg9]-Bradykinin | RPPGFSPF |
| [Des-His1,Glu9] Glucagon, amide | SQGTFTSEYSKYLDSRRAQDFVQWLMNT-NH2 |
| [DPro2,DPhe7,DTrp9] Substance P | R-DPro-KPQQ-DPhe-F-DTrp-LM-NH2 |
| [DTrp6]-LH-RH, amide | Glp-HWSY-DTrp-LRPG-NH2 |
| [Gln8]-C517 (LH-RH), chicken | {pGLU}-HWSYGLQPG |
| [Glu1] Fibrinopeptide B, human | EGVNDNEEGFFSAR |
| [Leu5]-Enkephalin | YGGFL |
| [Leu5]-Enkephalin, amide | YGGFL-NH2 |
| [Leu8] Renin Substrate Tetradecapeptide, rat | DRVYIHPLHLLYYS |
| [Met5]-Enkephalin, amide | YGGFM-NH2 |
| [Nle11]-Substance P | RPKPQQFFGL-{NLE}-NH2 |
| [pSer2, pSer5, pSer7]-CTD | Y-{pSer}-PT-{pSer}-P-{pSer}-YSPTSPSYSPTSPS |
| [pThr3]-CDK5 Substrate | PK-{pTHR}-PKKAKKL |
| [pTyr5] EGFR 988-993 | DADE-{pTyr}-L |
| [Pyr1]-Apelin-13 | {Glp}-RPRLSHKGPMPF |
| [Sar1, Ile8]-Angiotensin II | {SAR}-RVYIHPI |
| [Sar9,Met(O2)11]-Substance P | RPKPQQFF-{Sar}-LM[O2]-NH2 |
| [Sar9] Substance P | RPKPQQFF-{SAR}-LM-NH2 |
| [SER140]-PLP(139-151) | HSLGKWLGHPDKF |
| [Thi5,8,DPhe7] Bradykinin | RPPG-Thi-S-DPhe-Thi-R |
| [Tyr0] Bradykinin | YRPPGFSPFR |
| [Tyr0] Fibrinopeptide A, human | YADSGEGDFLAEGGGVR |
| [Tyr38, Phe42,46] Bone Gla Protein | YQEAFRRFFGPV |
| [Val8] Renin Substrate Tetradecapeptide, rat | DRVYIHPVHLLYYS |
| {Val1}-Exendin-3/4 | VSKQMEEEAVRLFIEWLKNGGPSSGAPPPS |
| 26Rfa, Hypothalamic Peptide, human | TSGPLGNLAEELNGYSRKKGGFSFRF-NH2 |
| 2-Furoyl-LIGRLO-amide | {Fur-2-oyl}-LIGRL-{Orn}-NH2 |
| 3Flag | DYKDDDDKGDYKDDDDKIDYKDDDDK |
| 3X FLAG peptide | MDYKDHDGDYKDHDIDYKDDDDK |
| 5FAM-DEEIYEELK-NH2 | 5FAM-DEEIYEELK-NH2 |
| 5FAM-ERRKSKSGA-NH2 | 5FAM-ERRKSKSGA-NH2 |
| 5FAM-NVKSKIGSTENLK-NH2 | 5FAM-NVKSKIGSTENLK-NH2 |
| 5FAM-QNPSRCSVSLSNVEA-NH2 | 5FAM-QNPSRCSVSLSNVEA-NH2 |
| 5FAM-RKRRQTSM | 5FAM-RKRRQTSM |
| 5FAM-RKRSRAEA-NH2 | 5FAM-RKRSRAEA-NH2 |
| 5FAM-RPRTSSF | 5FAM-RPRTSSF |
| 5FAM-RQMSFRL | 5FAM-RQMSFRL |
| 5FAM-RTKRSGSVYEPLKI-NH2 | 5FAM-RTKRSGSVYEPLKI-NH2 |
| 5-Tamra-DRVYIHP | 5-Tamra-DRVYIHP |
| Abaloparatide TFA | AVSEHQLLHDKGKSIQDLRRRELLEKLL-{Aib}-KLHTA-NH2 |
| Abl Cytosolic Substrate | EAIYAAPFAKKK |
| Abz-FR-K(Dnp)-P-OH | Abz-FR-K(Dnp)-P |
| Ac2-26 TFA | AMVSEFLKQAWFIENEEQEYVQTVK |
| Ac-DEVD-AFC | Ac-DEVD-7-amido-4-trifluoroMethylcoumarin |
| Acetalin-1 | Ac-RFMWMT-NH2 |
| Acetalin-2 | Ac-RFMWMR-NH2 |
| Acetalin-3 | Ac-RFMWMK-NH2 |
| Acetyl Angiotensinogen (1-14), porcine | Ac-DRVYIHPFHLLVYS |
| Acetyl, Angiotensinogen (1-14), human | Ac-DRVYIHPFHLVIHN |
| Acetyl-PHF6 amide TFA | Ac-VQIVYK-NH2 |
| Ac-IEPD-AFC | Ac-IEPD-AFC |
| Ac-IEVDID (TFA) | Ac-IEVDID |
| Ac-IEVDIDV (TFA) | Ac-IEVDIDV |
| Ac-IEVDIDVE (TFA) | Ac-IEVDIDVE |
| Ac-IEVDIDVEH (TFA) | Ac-IEVDIDVEH |
| Ac-Leu-Arg-AMC | Ac-Leu-Arg-AMC |
| Ac-MBP 1-11 | Ac-ASQKRPSQRSK |
| ACTH (1-10), human | SYSMEHFRWG |
| ACTH (1-13), human | SYSMEHFRWGKPV |
| ACTH (1-16), human | SYSMEHFRWGKPVGKK |
| ACTH (1-17), human | SYSMEHFRWGKPVGKKR |
| ACTH (1-24), human | SYSMEHFRWGKPVGKKRRPVKVYP |
| ACTH (1-39), human | SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF |
| ACTH (1-39), rat | SYSMEHFRWGKPVGKKRRPVKVYPNVAENESAEAFPLEF |
| ACTH (18-39), human | RPVKVYPNGAEDESAEAFPLEF |
| ACTH (4-10), human | MEHFRWG |
| ACTH (4-11), human | MEHFRWGK |
| ACTH (6-24), human | HFRWGKPVGKKRRPVKVYP |
| ACTH 11-24 | KPVGKKRRPVKVYP |
| ACTH 1-14 | SYSMEHFRWGKPVG |
| ACTH 22-39 | VYPNGAEDESAEAFPLEF |
| ACTH 34-39 | AFPLEF |
| Activated Protein C (390-404), human | YGVYTKVSRYLDWIH |
| Ac-VDID (TFA) | Ac-VDID |
| Acyl Carrier Protein (ACP) 65-74 | VQAAIDYING |
| Adipokinetic Hormone (AKH) (24-32), locust | Pyr-LNFTPNWGT-NH2 |
| Adrenomedullin (1-12), human | YRQSMNNFQGLR |
| Adrenomedullin (11-50), rat | STGCRFGTCTMQKLAHQIYQFTDKDKDGMAP RNKISPQGY-NH2(Disulfide bridge: Cys4-Cys9) |
| Adrenomedullin (1-50), rat | YRQSMNQGSRSTGCRFGTCTMQKLAHQIYQFTDKDKDGMAPRNKISPQGY-NH2 (Disulfide bridge: Cys14-Cys19) |
| Adrenomedullin (16-31), human | CRFGTCTVQKLAHQIY-NH2 |
| Adrenomedullin (22-52), human | TVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2 |
| Adrenomedullin (AM) (13-52), human | SFGCRFGTCTVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2 (Disulfide bridge: Cys16-Cys21) |
| Adrenomedullin (AM) (1-52), human TFA | YRQSMNNFQGLRSFGCRFGTCTVQKLAHQIYQFTDKDKDNVAPRSKISPQGY-NH2 (Disulfide bridge: Cys16-Cys21) |
| AGA-(C8R) HNG17, Humanin derivative | PAGASRLLLLTGEIDLP |
| a-Helical Corticotropin Releasing Factor (12-41) | FHLLREMLEMAKAEQEAEQAALNRLLLEEA-NH2 |
| Alexamorelin Met 1 | {d-Mrp}-Ala-Trp-{d-Phe} |
| Alisporivir intermediate-1 | DAVVLADALLV-{Aaa}-{Abu} |
| Allatostatin II | GDGRLYAFGL-NH2 |
| Allatostatin III | GGSLYSFGL-NH2 |
| Allatostatin IV | DRLYSFGL-NH2 |
| Allatostatins/Allatostatin I | APSGAQRLYGFGL-NH2 |
| Allergen Gal d 4 (46-61), chicken | NTDGSTDYGILQINSR |
| Alpha 1(I) Collagen (614-639), human | SAGFDFSFLPQPPQEKAHDGGRYYRA |
| ALX 40-4C Trifluoroacetate | Ac-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-{d-Arg}-NH2 |
| AMARA peptide | AMARAASAAALARRR |
| Amylin (8-37), rat | ATQRLANFLVRSSNNLGPVLPPTNVGSNTY-NH2 |
| Amylin (IAPP), feline | KCNTATCATQRLANFLIRSSNNLGAILSPTNVGSNTY-NH2 (Disulfide bridge: Cys2-Cys7) |
| Amylin, amide, human | KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY-NH2 (Disulfide bridge: Cys2-Cys7) |
| Amylin, amide, rat | KCNTATCATQRLANFLVRSSNNLGPVLPPTNVGSNTY-NH2 (Disulfide bridge: Cys2-Cys7) |
| Amyloid β-peptide (1-40) rat | DAEFGHDSGFEVRHQKLVFFAEDVGSNKGAIIGLMVGGVV |
| Angiogenin (108-122) TFA | ENGLPVHLDQSIFRR |
| Angiopep-2 | NH2-TFFYGGSRGKRNNFKTEEY-COOH |
| Angiotensin Converting Enzyme Inhibitor | Glp-WPRPQIPP |
| Angiotensin I Converting Enzyme Inhibitor | RPGFSPFR |
| Angiotensin I, human | DRVYIHPFHL |
| Angiotensin I/II 1-5 | DRVYI |
| Angiotensin I/II 1-6 | DRVYIH |
| Angiotensin II (1-4), human | DRVY |
| Angiotensin II (3-8), human | VYIHPF |
| Angiotensin II (5-8), human | IHPF |
| Angiotensin II 5-valine | DRVYVHPF |
| Angiotensin II Antipeptide | EGVYVHPV |
| Angiotensin II, human | DRVYIHPF |
| Angiotensin III, human | RVYIHPF |
| Angiotensinogen (1-13), human | DRVYIHPFHLVIH |
| Angiotensinogen (1-14), human | DRVYIHPFHLVIHN |
| Angiotensinogen (1-14), porcine | DRVYIHPFHLLVYS |
| Antennapedia Peptide | RQIKIWFQNRRMKWKK |
| Anti-Inflammatory Peptide 1 | MQMKKVLDS |
| Antioxidant peptide A | PHCKRM |
| Apamin | CNCKAPETALCARRCQQH-NH2 (Disulfide bridge: Cys1-Cys11;Cys3-Cys15) |
| Apelin-13, human, bovine | QRPRLSHKGPMPF |
| Apraglutide | HGDGSFSDEX FTILDLLAAR DFINWLIQTK ITD-NH2 |
| ARA290 | {Glp}-EQLERALNSS |
| Arg-Gly-Asp-Cys | RGDC |
| Arg-Gly-Asp-Ser (TFA) | RGDS |
| Arg-Gly-Glu-Ser | Arg-Gly-Glu-Ser |
| Argipressin | CYFQNCPRG-NH2 (Disulfide bridge: Cys1-Cys6) |
| Argireline | Ac-EEMQRR-NH2 |
| Asp-Asp-Asp-Asp-Asp | DDDDD |
| Astressin | {d-Phe}-HLLREVLE-NLE-ARAEQLAQEAHKNRKL-NLE-EII-NH2 |
| ATI-2341 | 1-Oxohexadecyl-MGYQKKLRSMTDKYRL |
| Atrial Natriuretic Peptide (ANP) (1-28), human, porcine Acetate | SLRRSSCFGGRMDRIGAQSGLGCNSFRY (Disulfide bridge: Cys7-Cys23) |
| Atrial Natriuretic Peptide (ANP) (1-28), rat | SLRRSSCFGGRIDRIGAQSGLGCNSFRY (Disulfide bridge: Cys7-Cys23) |
| Autocamtide 2 | KKALRRQETVDAL |
| Autocamtide 2, amide | KKALRRQETVDAL-NH2 |
| Axltide | KKSRGDYMTMQIG |
| AZP-531 | Cyclo(RVQSPEHQ) |
| Bacterial Sortase Substrate III, Abz/DNP | Abz-LPETG-K(Dnp)-NH2 |
| Bak BH3 | GQVGRQLAIIGDDINR |
| BAM-22P | YGGFMRRVGRPEWWMDYQKRYG |
| BCMA72-80 | YLMFLLRKI |
| BDC2.5 mimotope 1040-31 | YVRPLWVRME |
| Bim BH3, Peptide IV | DMRPEIWIAQELRRIGDEFNAYYARR |
| Biotinyl-Angiotensin I | Biotin-DRVYIHPFHL |
| BMf-BH3 | LQHRAEVQIARKLQCIADQFHRLHT |
| BNP-45 (rat) | SQDSAFRIQERLRNSKMAHSSSCFGQKIDRIGAVSRLGCDGLRLF(Disulfide bridge: Cys23-Cys39) |
| Boc-Gly-Gly-Phe-Gly-OH TFA | Boc-Gly-Gly-Phe-Gly-OH TFA |
| Boc-Ile-Glu-Gly-Arg-AMC | Boc-Ile-Glu-Gly-Arg-AMC |
| Bombesin | {Glp}-QRLGNQWAVGHLM-NH2 |
| Bombinin-Like Peptide BLP-1 | GIGASILSAGKSALKGLAKGLAEHFAN-NH2 |
| Bone Gla Protein (45-49) | FYGPV |
| BQ-3020 TFA | N-Acetyl-LMDKEAVYFAHLDIIW |
| Bradykinin | RPPGFSPFR |
| Bradykinin (1-3) | RPP |
| Bradykinin (1-5) | RPPGF |
| Bradykinin (1-6) | RPPGFS |
| Bradykinin (1-7) | RPPGFSP |
| Brain Derived Acidic Fibroblast Growth Factor (102-111) | HAEKHWFVGL |
| Brain Derived Acidic Fibroblast Growth Factor (1-11) | FNLPLGNYKKP |
| Brain Derived Basic Fibroblast Growth Factor (1-24) | PALPEDGGSGAFPPGHFKDPKRLY |
| Brain Natriuretic Peptide (BNP) (1-32), rat | NSKMAHSSSCFGQKIDRIGAVSRLGCDGLRLF (Disulfide bridge: Cys10-Cys26) |
| Buserelin Acetate | {pGlu}-HWSY-{d-S(tBu)}-LRP-NHEt |
| c(RGDfC) | c(RGDfC) |
| c(RGDfK) | c(RGDfK) |
| c(RGDKC) | c(RGDKC) |
| c(RGDyC) | c(RGDyC) |
| C3a 70-77 | ASHLGLAR |
| Caerulein, desulfated | Glp-QDYTGWMDF-NH2 |
| Calcineurin substrate (TFA) | DLDVPIPGRFDRRVSVAAE |
| Calcitonin Gene Related Peptide (CGRP) (83-119), rat | SCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2 (Disulfide bridge: Cys2-Cys7) |
| Calcitonin Gene Related Peptide (CGRP) II, rat | SCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSKAF-NH2 (Disulfide bridge: Cys2-Cys7) |
| Calcitonin salmon | CSNLSTCVLGKLSQELHKLQTYPRTNTGSGTP-NH2 (Disulfide bridge: Cys1-Cys7) |
| Calcitonin, eel TFA | CSNLSTCVLGKLSQELHKLQTYPRTDVGAGTP-NH2 (Disulfide bridge: Cys1-Cys7) |
| Calcitonin, human | CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP-NH2 (C1&C7 bridge) |
| Calcitonin, rat | CGNLSTCMLGTYTQDLNKFHTFPQTSIGVGAP-NH2 (C1&C7 bridge) |
| Calmodulin Binding Peptide 1 | GVMPREETDSKTASPWKSARLMVHTVATFNSIKELNERWRSLQQLA |
| Calmodulin-Dependent Protein Kinase II (290-309) | LKKFNARRKLKGAILTTMLA |
| Calmodulin-Dependent Protein Kinase II 281-309 | MHRQETVDCLKKFNARRKLKGAILTTMLA |
| cAMP Dependent PK Inhibitor (5-22), amide | TTYADFIASGRTGRRNAI-NH2 |
| Carcinoembryonic Antigen CEA | YLSGANLNL |
| Cardiotoxin Analog (CTX) IV (6-12) (TFA) | LIPPFWK-NH2 |
| CART (55-76), rat | IPIYEKKYGQVPMCDAGEQCAV(Cys14&Cys20 bridge) |
| Casein Kinase II Substrate | RRREEETEEE |
| Casein Kinase Substrates 3 | RRKDLHDDEEDEAMSITA |
| CD36 Peptide P (139-155) | CNLAVAAASHIYQNQFVQ |
| CD36 Peptide P (93-110) | YRVRFLAKENVTQDAEDNC |
| CDK2 | HHASPRK |
| Cecropin A | KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK-NH2 |
| Cecropin A-melittin hybrid peptide [CA(1-7)M(2-9)NH2] | KWKLFKKIGAVLKVL-NH2 |
| Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL-NH2 |
| Cecropin P1, porcine | SWLSKTAKKLENSAKKRISEGIAIAIQGGPR |
| CEF1, Influenza Matrix Protein M1 58-66 | GILGFVFTL |
| CEF14, EBV Rta Protein 28-37 | DYCNVLNKEF |
| CEF19, Epstein-Barr Virus latent NA-3A 458-466 | YPLHEQHGM |
| CEF27, Epstein-Barr Virus BRLF-1 lytic 148-156 | RVRAYTYSK |
| CEF3 | SIIPSGPLK |
| CEF4 | RVLSFIKGTK |
| CEF6 | LPFDKTTVM |
| CEF7, Influenza Virus NP 380-388 | ELRSRYWAI |
| CEF8, Influenza Virus NP 383-391 | SRYWAIRTR |
| Ceratotoxin A | SIGSALKKALPVAKKIGKIALPIAKAALP |
| Ceratotoxin B | SIGSAFKKALPVAKKIGKAALPIAKAALP |
| Cerebellin | SGSAKVAFSAIRSTNH |
| CH 5450 | Z-Ile-Glu-Pro-Phe-Ome |
| Chemerin-9 149-157 | YFPGQFAFS |
| Chlorotoxin(linear) | MCMPCFTTDHQMARKCDDCCGGKGRGKCYGPQCLCR-NH2 |
| Cholecystokinin, CCK Octapeptide (26-33), Non-Sulfated form | DYMGWMDF-NH2 |
| Cholecystokinin, CCK Tetrapeptide (30-33) | WMDF-NH2 |
| Chromostatin, bovine | SDEDSDGDRPQASPGLGPGP |
| CLIP 86-100 | PVSKMRMATPLLMQA |
| c-Myc Peptide Trifluoroacetate | EQKLISEEDL |
| Colivelin | SALLRSIPAPAGASRLLLLTGEIDLP |
| Collagen Binding Fragment | CQDSETRTFY |
| Competence-Stimulating Peptide-12261 | EIRQTHNIFFNFFKRR |
| Compstatin | ICVVQDWGHHRCT-NH2 (Disulfide bridge: Cys2-Cys12) |
| Conopressin S | CIIRNCPRG-NH2 (Disulfide bridge: Cys1-Cys6) |
| Corazonin | Glp-TFQYSRGWTN-NH2 |
| Corticotropin-releasing factor human | SEEPPISLDLTFHLLREVLEMARAEQLAQQAHSNRKLMEII-NH2 |
| Cortistatin 14, human, rat | PCKNFFWKTFSSCK (Disulfide bridge: Cys2-Cys13) |
| Cortistatin 29 (1-13) | Glp-ERPPLQQPPHRD |
| Cortistatin-14 | PCKNFFWKTFSSCK-NH2 (Disulfide bridge: Cys2-Cys13) |
| C-Peptide, dog | EVEDLQVRDVELAGAPGEGGLQPLALEGALQ |
| C-Reactive Protein (CRP) 174-185 | IYLGGPFSPNVL |
| C-Reactive Protein (CRP) 201-206 | KPQLWP |
| C-Reactive Protein (CRP) 77-82 | VGGSEI |
| CREBtide | KRREILSRRPSYR |
| CRF, bovine | SQEPPISLDLTFHLLREVLEMTKADQLAQQAHNNRKLLDIA-NH2 |
| Crustacean Cardioactive Peptide CCAP | PFCNAFTGC |
| C-telopeptide | EKAHDGGR |
| CTTHWGFTLC, CYCLIC | CTTHWGFTLC (Disulfide Bridge: Cys1-Cys10) |
| C-Type Natriuretic Peptide (1-53), human | DLRVDTKSRAAWARLLQEHPNARKYKGANKKGLSKGCFGLKLDRIGSMSGLGC |
| C-Type Natriuretic Peptide (CNP) (1-22), human | GLSKGCFGLKLDRIGSMSGLGC (Disulfide bridge: Cys6-Cys22) |
| Cyclic MKEY | CKEYFYTSSKSSNLAVVFVTRC |
| Cyclic somatostatin | HAGCKNFFWKTFTSC-OH (Disulfide bridge: Cys3-Cys14) |
| Cyclo(Phe-Pro) | Cyclo(Phe-Pro) |
| Cyclo(RADfK) | Cyclo(Ala-Asp-Phe-Lys-Arg) |
| Cyclo(RGDyK) | Cyclo(RGDyK) |
| Cyclosporin A-Derivative 1 | LVLADALLV-{Aaa}-{Abu}-{Sar} |
| Cyclosporin A-Derivative 2 | VLADALLV-{Aaa}-{Abu}-{Sar} |
| CYN 154806 | Ac-FCYWKTCY-NH2 (Disulfide bridge: Cys2-Cys7) |
| CysHHC10 TFA | CKRWWKWIRW-NH2 |
| Cys-TAT(47-57) | CYGRKKRRQRRR-NH2 |
| DAMGO | Y-{d-Ala}-G-{Me-Phe}-G-ol |
| DAPTA | ASTTTNYT-NH2 |
| Delta-Sleep Inducing Peptide | WAGGDASGE |
| Dermaseptin | ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ |
| Dermorphin Analog | Y-{d-Arg}-F-{SAR}-YPS-NH2 |
| Diazepam-Binding Inhibitor Fragment, human | QATVGDINTERPGMLDFTGK |
| Difopein TFA | SADGAPHCVPRDLSWLDLEANMCLPGAAGLDSADGAPHCVPRDLSWLDLEANMCLPGAAGLE |
| D-Lys(Z)-Pro-Arg-pNA | {d-Lys(Z)}-PR-pNA |
| D-Lys(Z)-Pro-Arg-pNA diacetate | {d-Lys(Z)}-P-R-pNA |
| Dynorphin (2-17), amide, porcine | GGFLRRIRPKLKWDNQ-NH2 |
| Dynorphin A (1-13), amide, porcine | YGGFLRRIRPKLK-NH2 |
| Dynorphin A (1-13), porcine | YGGFLRRIRPKLK |
| Dynorphin A (1-17) | YGGFLRRIRPKLKWDNQ |
| Dynorphin A (2-17), porcine | GGFLRRIRPKLKWDNQ |
| Dynorphin A 1-10 | YGGFLRRIRP |
| Dynorphin A amide, porcine | YGGFLRRIRPKLKWDNQ-NH2 |
| Dynorphin B (1-13) | YGGFLRRQFKVVT |
| Dynorphin B (1-9) | YGGFLRRQF |
| EGF Receptor Substrate 2 Phospho-Tyr5 | HDADE-{pTyr}-LIPQQG-OH |
| EGFRvIII peptide PEPvIII | LEEKKGNYVVTDHC |
| Egg Laying Hormone, aplysia | ISINQDLKAITDMLLTEQIRERQRYLADLRQRLLEK-NH2 |
| Elamipretide | {d-Arg}-Dmt-KF-NH2 |
| Eledoisin | {Glp}-PSKDAFIGLM-NH2 |
| Eledoisin Related Peptide | KFIGLM-NH2 |
| Endothelin-2, human | CSCSSWLDKECVYFCHLDIIW (Disulfide bridge: Cys1-Cys15, Cys3-Cys11) |
| Endothelin-3, human, mouse, rabbit, rat | CTCFTYKDKECVYYCHLDIIW(Disulfide bridge: Cys1-Cys15, Cys3-Cys11) |
| Enfuvirtide | Ac-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-NH2 |
| Enterostatin, human, mouse, rat | APGPR |
| Epidermal Growth Factor Receptor Peptide (985-996) | DVVDADEYLIPQ |
| Epithalon TFA | AEDG |
| Etelcalcetide hydrochloride | C'-Ac-d-C-d-A-d-R-d-R-d-R-d-A-d-R-NH2 (Disulfide bridge: Cys1'-Cys1) |
| EXENDIN (9-39) | DLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 |
| Exendin derivative 1 | HAEGTFTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPSLMNPQRSTVWY |
| Exendin-3 | HSDGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 |
| Exendin-3/4 (59-86) | KQMEEEAVRLFIEWLKNGGPSSGAPPPS |
| Exendin-3/4 (64-86) | EAVRLFIEWLKNGGPSSGAPPPS |
| Exendin-4 | HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2 |
| Fam-Bradykinin | 5FAM-RPPGFSPFR |
| Fertirelin | {Glp}-HWSYGLRP |
| FFAGLDD | FFAGLDD |
| FHV Coat-(35–49) | RRRRNRTRRNRRRVR |
| Fibrinogen Binding Inhibitor Peptide | HHLGGAKQAGDV |
| Fibrinogen-Binding Peptide | EHIPA |
| Fibrinopeptide A, human | ADSGEGDFLAEGGGVR |
| Fibrinopeptide B, human | {Glp}-GVNDNEEGFFSAR |
| Fibronectin Active Fragment Control | GRGES |
| Fibronectin Adhesion-promoting Peptide | WQPPRARI |
| Fibronectin CS1 Peptide | EILDVPST |
| Flag Peptide | DYKDDDDK |
| Flagelin 22(TFA) | QRLSTGSRINSAKDDAAGLQIA |
| FliC, Serotype a (427-441), S.paratyphi A | VQNRFNSAITNLGNT |
| Fmoc-N-Me-Ala-OH | Fmoc-N-Me-Ala-OH |
| Fmoc-N-Me-Leu-OH | Fmoc-N-Me-Leu-OH |
| Fmoc-N-Me-Phe-OH | Fmoc-N-Me-Phe-OH |
| Fmoc-Val-Cit-PAB-PNP | Fmoc-V-Cit-PAB-PNP |
| FMRF | FMRF |
| FMRF-amide | FMRF-NH2 |
| Foxy-5 | MDGCEL |
| G280-9 | YLEPGPVTA |
| Galanin (1-16), mouse, porcine, rat TFA | GWTLNSAGYLLGPHAI |
| Galanin (1-19), human | GWTLNSAGYLLGPHAVGNH |
| Galanin, human | GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS |
| Galanin, rat | GWTLNSAGYLLGPHAIDNHRSFSDKHGLT-NH2 |
| Galantide | GWTLNSAGYLLGPQQFFGLM-NH2 |
| Gap26 | VCYDKSFPISHVR |
| GAP27 | SRPTEKTIFII |
| Gastrin 1, human | Pyr-GPWLEEEEEAYGWMDF-CONH2 |
| Gastrin I (1-14), human | Glp-GPWLEEEEEAYGW |
| Gastrin-Releasing Peptide, human | VPLPAGGGTVLTKMYPRGNHWAVGHLM-NH2 |
| GHRF (1-29), amide, human | YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 |
| GHRF (1-29), amide, rat | HADAIFTSSYRRILGQLYARKLLHEIMNR-NH2 |
| GIP (1-30) amide (Human) | YAEGTFISDYSIAMDKIHQQDFVNWLLAQK-NH2 |
| GLGPNPCRKKCYKRDFLGR | GLGPNPCRKKCYKRDFLGR |
| GLP-1 (7-36), amide, chicken, common turkey | HAEGTYTSDITSYLEGQAAKEFIAWLVNGR-NH2 |
| GLP-1 (7-37) (human, bovine, guinea pig, mouse, rat) | HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG |
| GLP-1 moiety from Dulaglutide | HGEGTFTSDVSSYLEEQAAKEFIAWLVKGGG |
| GLP-1(7-36) Acetate | HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRNH2 |
| GLP-1(7-37) | HAEGTFTSDVSSYLEGQAAKEFIAWLVKG-R-G |
| GLP-1/Glucagon-Like Peptide, amide, human | HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGR-NH2 |
| GLP-1/Glucagon-Like Peptide, human | HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG |
| GLP-2, human | HADGSFSDEMNTILDNLAARDFINWLIQTKITD |
| Glucagon (19-29), human | AQDFVQWLMNT |
| Glucagon, human | HSQGTFTSDYSKYLDSRRAQDFVQWLMNT |
| Glucagon-Like Peptide II, human | HADGSFSDEMNTILDNLAARDFINWLIQTKITDR |
| Glucagon-Like Peptide II, rat | HADGSFSDEMNTILDNLATRDFINWLIQTKITD |
| Gluten Exorphin B5 | YGGWL |
| Gluten Exorphin C | YPISL |
| Gly6 | GGGGGG |
| Gly-Arg-Gly-Asp-Ser | GRGDS |
| Glycoprotein 276-286 | SGVENPGGYCL |
| Gly-Phe-Arg | GFR |
| GnRH-I | Pyr-HWSYGLRPG-NH2 |
| GP(33-41) | KAVYNFATC |
| Gp100 (25-33), human | KVPRNQDWL |
| Gp100 619-627 | RLMKQDFSV |
| GPRP acetate | GPRP |
| G-R-G-D-S-P | GRGDSP |
| GRGDSPC | GRGDSPC |
| GRGDSPK | GRGDSPK |
| GroES mobile loop | ETKSAGGIVLTGS |
| GsMTx4 | GCLEFWWKCNPNDDKCCRPKLKCSKLFKLCNFSF |
| GTFTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS | GTFTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS |
| GTP-Binding Protein Fragment, Gs alpha | CKQLQKDKQVYRATHR |
| HA Peptide | YPYDVPDYA |
| HAE | His-Ala-Glu |
| HAEGT | HAEGT |
| HAEGTFTSD | HAEGTFTSD |
| HAEGTFTSDVS | HAEGTFTSDVS |
| HAEGTFTSDVSSYLE | HAEGTFTSDVSSYLE |
| H-Ala-Ala-Tyr-OH | H-Ala-Ala-Tyr-OH |
| Handle region peptide, rat | RILLKKMPSV |
| HCGRP-(8-37) | VTHRLAGLLSRSGGVVKNNFVPTNVGSKAF |
| Hemoglobin (Hb) (64-76) | GKKVITAFNEGLK |
| Hemokinin 1 (mouse) | RSRTRQFYGLM-NH2 |
| Hemorphin-7 | YPWTQRF |
| Hepatitis B Virus Core 128-140 | TPPAYRPPNAPIL |
| HER2/neu (654-662) GP2 | IISAVVGIL |
| HEX3 | KYSPSNVKI |
| Hexa His | HHHHHH |
| H-Gly-Gly-Pro-OH | H-Gly-Gly-Pro-OH |
| H-Gly-Pro-OH | H-Gly-Pro-OH |
| HIF-1 alpha 556-574 | DLDLEMLAPYIPMDDDFQL |
| H-Ile-Pro-Pro-OH | Ile-Pro-Pro |
| His-[D-2-ME-Trp]-Ala | His-{d-2-Me-Trp}-Ala |
| His-Pro | His-Pro |
| His-Pro hydrochloride | His-Pro hydrochloride |
| Histatin 5 | DSHAKRHHGYKRKFHEKHHSHRGY |
| Histone H1-derived Peptide | GGGPATPKKAKKL |
| Histone H4 (2-21) | SGRGKGGKGLGKGGAKRHRK |
| HIV (gp120) Fragment (318-327) | RGPGRAFVTI |
| HIV (gp41) Fragment | AVGIGA |
| HIV gag peptide 197-205 | AMQMLKETI |
| HIV p17 Gag 77-85 | SLYNTVATL |
| HIV-1 env Protein gp41 (1-23) amide (isolates BRU/JRCSF) | AVGIGALFLGFLGAAGSTMGARS-NH2 |
| HIV-1 gag Protein p24 (194-210) | ANPDCKTILKALGPAAT |
| HIV-1 Rev 34-50 | TRQARRNRRRRWRERQR |
| HIV-1 TAT 48-60 | GRKKRRQRRRPPQ |
| HIV-1 tat Protein (1-9) | MDPVDPNIE |
| HIV-1 tat Protein (49-57) | RKKRRQRRR |
| HIV-1 TAT Protein Peptide | NH2-YGRKKRRQRRR-COOH |
| HPV16 E7 86-93 | TLGIVCPI |
| HPV16-E711-20 epitope | YMLDLQPETT |
| Hsp70-derived octapeptide | GPTIEEVD |
| HSV-gB2 498-505 | SSIEFARL |
| Human CMV pp65 (495-503) | NLVPMVATV |
| Human growth hormone-releasing factor | YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NH2 |
| Human Papillomavirus (HPV) E7 protein 49-57 | RAHYNIVTF |
| H-Val-Pro-Pro-OH | H-Val-Pro-Pro-OH |
| Hypercalcemia Malignancy Factor (1-34), amide, human | AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2 |
| Hypercalcemia Malignancy Factor (1-34), human | AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA |
| IFN-α Receptor Recognition Peptide 1 | CLKDRHD |
| IGF-I (24-41) TFA | YFNKPTGYGSSSRRAPQT |
| IGF-I (30-41) TFA | GYGSSSRRAPQT |
| IKKγ NBD Inhibitory Peptide | DRQIKIWFQNRRMKWKKTALDWSWLQTE |
| Ile-Thr-Asp-Gln-Val-Pro-Phe-Ser-Val | ITDQVPFSV |
| Indolicidin | ILPWKWPWWPWRR-NH2 |
| Influenza A NP(366-374) Strain A/PR/8/35 | ASNENMETM |
| Influenza HA 126-138 | HNTNGVTAASSHE |
| Influenza HA 307-319 | PKYVKQNTLKLAT |
| Influenza HA 518-526 | IYSTVASSL |
| Influenza NP 147-155 | TYQRTRALV |
| Insulin alpha-chain 1-13 | KRGIVEQCCTSICSL |
| Insulin B (9 - 23) | SHLVEALYLVCGERG |
| Interleukin (IL)-6 Receptor | TSLPVQDSSSVP |
| Interphotoreceptor Retinoid Binding Protein Fragment IRBP | SGIPYIISYLHPGNTILHVD |
| Interphotoreceptor retinoid-binding protein(668-687) | LAQGAYRTAVDLESLASQLT |
| IRBP (1-20), human | GPTHLFQPSLVLDMAKVLLD |
| iRGD | c(CRGDKGPDC) |
| IRL-1620 TFA | Suc-DEEAVYFAHLDIIW |
| IRL-1720 | Ac-DKEAVYFAHLDIIW |
| Iα52 | ASFEAQGALANIAVDKA |
| JAG-1, scrambled | RCGPDCFDNYGRYKYCF |
| Jagged-1 188-204 | CDDYYYGFGCNKFCRPR |
| Kassinin | DVPKSDQFVGLM-NH2 |
| Katacalcin | DMSSDLERDHRPHVSMPQNAN |
| Kemptide | LRRASLG |
| Kemptide Phospho-Ser5 | LRRA-{pSer}-LG |
| Kinetensin | IARRHPYFL |
| Kisspeptin-10, human (TFA) | YNWNSFGLRF-NH2 |
| Kisspeptin-10, rat | YNWNSFGLRY-NH2 |
| KKI-5 | Ac-PFRSVQ-NH2 |
| Kv3, Channel Containing Protein 567-585 | CKESPVIAKYMPTEAVRVT |
| L-Leucyl-L-alanine | L-Leucyl-L-alanine |
| Lactoferricin, bovine, (BLFC) | RRWQWRMKKLG |
| Lactoferrin (17-41) TFA | FKCRRWQWRMKKLGAPSITCVRRAF (Disulfide bridge: Cys3-Cys20) |
| LAH4 | KKALLALALHHLAHLALHLALALKKA |
| Laminin (925-933) | CDPGYIGSR |
| Laminin (929-933) | YIGSR |
| Laminin A Chain (2091-2108) | CSRARKQAASIKVAVSADR |
| Laminin Penta Peptide, amide | YIGSR-NH2 |
| LCMV gp33-41 | KAVYNFATM |
| Lecirelin | {Glp}-HWSYVLRP |
| LEP(116-130)(mouse) | SCSLPQTSGLQKPES-NH2 |
| Leptin (116-130), mouse | SCSLPQTSGLQKPES |
| Leptin (22-56), human | VPIQKVQDDTKTLIKTIVTRINDISHTQSVSSKQK |
| Leptin (93-105), human | NVIQISNDLENLR |
| Leucokinin I | DPAFNSWG |
| Leucokinin VIII | GASFYSWG-NH2 |
| LGnRH-III, lamprey | {pGLP}-HWSHDWKPG-NH2 |
| LH-RH, Free Acid | Glp-HWSYGLRPG |
| LH-RH, human, Gonadoreline | Glp-HWSYGLRPG-NH2 |
| LH-RH, lamprey | Glp-HYSLEWKPG-NH2 |
| LH-RH, salmon | Glp-HWSYGWLPG-NH2 |
| Lixisenatide | HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSKKKKKK-NH2 |
| L-JNKI-1 | DQSRPVQPFLNLTTPRKPRPPRRRQRRKKRG-NH2 |
| LL-37 | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES |
| LL-37 scrambled peptide | GLKLRFEFSKIKGEFLKTPEVRFRDIKLKDNRISVQR |
| LL-37, acetylated,amidated | Ac-LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES-NH2 |
| LSKL, Inhibitor of Thrombospondin TSP-1 | LSKL |
| LTX-315 | KKWWKKW-Dip-K-NH2 |
| Luteinizing Hormone Releasing Hormone (LH-RH), human | {Glp}-HWSYGLRPG-NH2 |
| Lysozyme | RVVRDPQGIRAWVAWRNR |
| M-2420 | Methoxycoumarin-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Lys-dinitrophenyl |
| M35 | GWTLNSAGYLLGPPPGFSPFR-NH2 |
| M40 | GWTLNSAGYLLGPPPALALA-NH2 |
| Magainin 2 | GIGKFLHSAKKFGKAFVGEIMNS |
| Magainin I | GIGKFLHSAGKFGKAFVGEIMKS |
| Magainin Spacer Peptide | DAEAVGPEAFADQDLDEREVR |
| Mage-1 Antigen (161-169), human | EADPTGHSY |
| MAGE-3 Antigen (167-176), human | MEVDPIGHLY |
| MAGE-3 Antigen (271-279), human | FLWGPRALV |
| MAGE-A3 195-203 | IMPKAGLLI |
| Malantide | RTKRSGSVYEPLKI |
| MARCKS Peptide(151-175), Phosphorylated | KKKKKRF-{pSer}-FKK-{pSer}-FKLSGF-{pSer}-FKKNKK |
| MARK Substrate | NVKSKIGSTENLK |
| MART-1 (26-35) human | EAAGIGILTV |
| Mas7 | INLKALAALAKALL-NH2 |
| Mast cell degranulating peptide (28-49) | IKCNCKRHVIKPHICRKICGKN-NH2 |
| Mast Cell Degranulating Peptide HR-1 | INLKAIAALVKKVL-NH2 |
| Mast Cell Degranulating Peptide HR-2 | FLPLILGKLVKGLL-NH2 |
| Mastoparan | INLKALAALAKKIL-NH2 |
| Mastoparan X | INWKGIAAMAKKLL-NH2 |
| MCA-SEVNLDAEFR-K(Dnp)-RR, amide | MCA-SEVNLDAEFR-K(Dnp)-RR-NH2 |
| Melanin Concentrating Hormone, salmon | DTMRCMVGRVYRPCWEV (Disulfide bridge: Cys5-Cys14) |
| Melanocyte-Stimulating Hormone-Release Inhibiting Factor | PLG-NH2 |
| Melittin | GIGAVLKVLTTGLPALISWIKRKRQQ-NH2 |
| Men 10376 | DY-DTrp-V-DTrp-DTrp-K-NH2 |
| Men 10376 TFA | Asp-Tyr-{d-Trp}-Val-{d-Trp}-{d-Trp}-Lys-NH2 |
| Met-Enkephalin | YGGFM |
| MG-132 | RPKPQQFFGLM-NH2 |
| Microtubule-associated protein tau (26-44) | QGGYTMHQDQEGDTDAGLK |
| Mini Gastrin I, human | LEEEEEAYGWMDF-NH2 |
| MOG 35-55 | MEVGWYRSPFSRVVHLYRNGK |
| Moth Cytochrome C (MCC) 88-103 | ANERADLIAYLKQATK |
| Motilin, canine | FVPIFTHSELQKIREKERNKGQ |
| Motilin, human, porcine | FVPIFTYGELQRMQEKERNKGQ |
| MPG, HIV related | GALFLGFLGAAGSTMGAWSQPKSKRKV |
| mTRP-2 180-188 | SVYDFFVWL |
| MUC5AC motif peptide | GTTPSPVPTTSTTSAP |
| Murepavadin TFA | Cyclo(AS-{d-Pro}-PTWI-{Dab}-{Orn}-{d-Dab}-{Dab}-W-{Dab}-{Dab}) |
| Myelin Basic Protein (68-84), guinea pig | YGSLPQKSQRSQDEN |
| Myelin Basic Protein (87-99) (human, bovine, rat) | VHFFKNIVTPRTP |
| Myelopeptide-2 (MP-2) | LVVYPW |
| Myomodulin | PMSMLRL-NH2 |
| Myosin Kinase Inhibiting Peptide | KKRAARATS-NH2 |
| N-Acetyl, ACTH (1-17), human | Ac-SYSMEHFRWGKPVGKKR |
| N-Acetyl-Ser-Asp-Lys-Pro | Ac-SDKP |
| N-Acetyl-α-Endorphin | Ac-YGGFMTSEKSQTPLVT |
| N-Boc-Phe-Leu-Phe-Leu-Phe | N-Boc-Phe-Leu-Phe-Leu-Phe |
| N-CBZ-Phe-Arg-AMC | CBZ-FR-AMC |
| Nesiritide | SPKMVQGSGCFGRKMDRISSSSGLGCKVLRRH (Disulfide bridge: Cys10-Cys26) |
| Neurokinin A / Substance K | HKTDSFVGLM-NH2 |
| Neurokinin A(4-10) | DSFVGLM-NH2 |
| Neurokinin B | DMHDFFVGLM-NH2 |
| Neuromedin (U25), human | FRVDEEFQSPFASQSRGYFLFRPRN-NH2 |
| Neuromedin B | GNLWATGHFM-NH2 |
| Neuromedin C | GNHWAVGHLM-NH2 |
| Neuromedin N | KIPYIL |
| Neuromedin U, rat | YKVNEYQGPVAPSGGFFLFRPRN-NH2 |
| Neuronostatin-13 human | LRQFLQKSLAAAA-NH2 |
| Neuropeptide AF (93-110), Human | AGEGLNSQFWSLAAPQRF-NH2 |
| Neuropeptide EI, rat | EIGDEENSAKFPI-NH2 |
| Neuropeptide FF | FLFQPQRF-NH2 |
| Neuropeptide K, porcine | DADSSIEKQVALLKALYGHGQISHKRHKTDSFVGLM-NH2 |
| Neuropeptide W-23(human) | WYKHVASPRYHTVGRAAGLMGL |
| Neuropeptide Y (13-36), human | PAEDMARYYSALRHYINLITRQRY-NH2 |
| Neuropeptide Y (22-36) | SALRHYINLITRQRY-NH2 |
| Neuropeptide Y(29-64) | YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY |
| Neuropeptide Y, human | YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2 |
| Neurotensin | Pyr-LYENKPRRPYIL |
| Neurotensin (8-13) | RRPYIL |
| NFAT Inhibitor | MAGPHPVIVITGPHEE |
| N-Formyl-Met-Ala-Ser | Formyl-MAS |
| N-Formyl-Met-Leu-Phe | Formyl-MLF |
| N-Formyl-Met-Leu-Phe-Lys | Formyl-MLFK |
| N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys | N-Formyl-{NLE}-LF-{NLE}-YK |
| NGR peptide Trifluoroacetate | CNGRCG |
| NH2-KLGADTDGEQDQHMTYGGQ-COOH | KLGADTDGEQDQHMTYGGQ |
| NLS PKKKRKV | PKKKRKV |
| Nociceptin (1-13), amide | FGGFTGARKSARK-NH2 |
| Nociceptin / Orphanin FQ | FGGFTGARKSARKLANQ |
| Nocistatin | EQKQLQ |
| NT 13 | TPPT |
| NTB (Naltriben) | DPhe-CY-DTrp-Orn-T-Pen-T-NH2(Cys2&Pen7 bridge) |
| N-terminally acetylated Endomorphin-1 | Ac-LYLPLWLF-NH2 |
| N-terminally acetylated Leu-enkephalin | Ac-LYGGLFDL-COOH |
| Nuclear pore complex protein Nup98 315-360 | Ac-MGLFGVTQASQPGGLFGTATNTSTGTAFGTGTGLFGQTNTGFGAV |
| Nucleoprotein 118-126 | RPQASGVYM |
| Nucleoprotein 396-404 | FQPQNGQFI |
| NY-BR-1 p904 A2 | SLSKILDTV |
| Obestatin (human) | FNAPFDVGIKLSGVQYQQHSQAL-NH2 |
| Octreotide | FCFWKTCT (Disulfide bridge: Cys2-Cys7) |
| Orexin B, canine | RPGPPGLQGRLQRLLQASGNHAAGILTM-NH2 |
| Orexin B, human | RSGPPGLQGRLQRLLQASGNHAAGILTM-NH2 |
| Orexin B, rat, mouse | RPGPPGLQGRLQRLLQANGNHAAGILTM-NH2 |
| Ornipressin | CYFQNCP-{Orn}-G-NH2 (Disulfide bridge: Cys1-Cys6) |
| Osteocalcin (37-49), human | GFQEAYRRFYGPV |
| Osteogenic Growth Peptide, OGP | ALKRQGRTLYGFGG |
| OV-1, sheep | KNLRRIIRKIIHIIKKYG |
| OVA 323-339 | ISQAVHAAHAEINEAGR |
| OVA G4 peptide | SIIGFEKL |
| OVA peptide (257-264) | SIINFEKL |
| OVA sequence 323-336 | ISQAVHAAHAEINE |
| p2Ca | LSPFPFDL |
| P34cdc2 Kinase Substrate Peptide | ADAQHATPPKKKRKVEDPKDF |
| p5 Ligand for Dnak and DnaJ | CLLLSAPRR |
| p53 17-26 | ETFSDLWKLL |
| PA (224-233), Influenza | SSLENFRAYV |
| PACAP (1-27), human, ovine, rat | HSDGIFTDSYSRYRKQMAVKKYLAAVL-NH2 |
| PACAP (1-38), human, ovine, rat | HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2 |
| PACAP (6-27), human, ovine, rat | FTDSYSRYRKQMAVKKYLAAVL-NH2 |
| PACAP (6-38), human, ovine, rat | FTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2 |
| PACAP-38 (16-38), human, mouse, rat | QMAVKKYLAAVLGKRYKQRVKNK-NH2 |
| PACAP-38 (31-38), human, mouse, rat | YKQRVKNK-NH2 |
| PACAP-Related Peptide (PRP), human | DVAHGILNEAYRKVLDQLSAGKHLQSLVA |
| PACAP-Related Peptide (PRP), rat | DVAHEILNEAYRKVLDQLSARKYLQSMVA |
| Palmitoyl Tetrapeptide-3 | Palm-GQPR |
| Pancreatic Polypeptide (human) | APLEPVYPGDNATPEQMAQYAADLRRYINMLTRPRY-NH2 |
| Pancreatic Polypeptide (rat) | APLEPMYPGDYATHEQRAQYETQLRRYINTLTRPRY-NH2 |
| Pancreatic Polypeptide, bovine | APLEPEYPGDNATPEQMAQYAAELRRYINMLTRPRY-NH2 |
| PAR - 1 Agonist;Protease - Activated Receptor - 1 | TFLLRN |
| PAR-4 (1-6) (human) | GYPGQV |
| PAR-4 (1-6) (mouse) | GYPGKF |
| PAR-4 (1-6) amide (human) | GYPGQV-NH2 |
| PAR-4 (1-6) amide (mouse) | GYPGKF-NH2 |
| PAR-4 Agonist Peptide, amide | AYPGKF-NH2 |
| Parasin I (TFA) | KGRGKQGGKVRAKAKTRSS |
| Parathyroid Hormone (1-34), bovine | AVSEIQFMHNLGKHLSSMERVEWLRKKLQDVHNF |
| Parathyroid Hormone (1-34), rat | AVSEIQLMHNLGKHLASVERMQWLRKKLQDVHNF |
| Pep-1 | KETWWETWWTEWSQPKKKRKV |
| Peptide 401 | IKCNCKRHVIKPHICRKICGKN-NH2 (Disulfide bridge: Cys3-Cys15, Cys5-Cys19) |
| Peptide C105Y | CSIPPEVKFNKPFVYLI |
| Peptide M | DTNLASSTIIKEGIDKTV |
| Peptide T | ASTTTNYT |
| Peptide YY (PYY) (3-36), human | IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY-NH2 |
| Peptide YY (PYY), human | YPIKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY-NH2 |
| PGLa | GMASKAGAIAGKIAKVALKAL-NH2 |
| pGlu-Pro-Arg-MNA | {pGlu}-PR-MNA |
| pGlu-Pro-Arg-MNA monoacetate | {pGlu}-Pro-Arg-MNA |
| Phe-Met-Arg-Phe Like Peptide | {pGLU}-DPFLRF |
| PHI, rat | HADGVFTSDYSRLLGQISAKKYLESLI-NH2 |
| Phosphate Acceptor Peptide | RRKASGPPV |
| Phosphorylase Kinase b-Subunit (420-436) | KRNPGSQKRFPSNCGRD |
| P-H-P-F-H-F-F-V-Y-K | PHPFHFFVYK |
| Phyllomedusin | Glp-NPNRFIGLM-NH2 |
| Physalaemin | Glp-ADPNKFYGLM-NH2 |
| Piscidin-1 (22-42) | GFIFHIIKGLFHAGKMIHGLV-NH2 |
| PKG Substrate | RKRSRAE |
| Platelet Factor 4 (58-70), human | PLYKKIIKKLLES |
| PLP 139-151 | HCLGKWLGHPDKF |
| PN: US20040072744 SEQID: 2 claimed protein | NLGEHPVCDS |
| Prepro VIP (111-122), human | VSSNISEDPVPV |
| Prepro VIP (81-122), human | HADGVFTSDFSKLLGQLSAKKYLESLMGKRVSSNISEDPVPV |
| Pressinoic Acid | CYFQNC (Disulfide bridge: Cys1-Cys6) |
| Proadrenomedullin (45-92), human | ELRMSSSYPTGLADVKAGPAQTLIRPQDMKGASRSPEDSSPDAARIRV |
| Pro-Adrenomedullin (N-20), human | ARLDVASEFRKKWNKWALSR-NH2 |
| Pro-Adrenomedullin (N-20), porcine | ARLDVAAEFRKKWNKWALSR-NH2 |
| Pro-Adrenomedullin (N-20), rat | ARLDTSSQFRKKWNKWALSR-NH2 |
| Proctolin | RYLPT |
| Proinsulin C-Peptide (55-89), ?human | RREAEDLQVGQVELGGGPGAGSLQPLALEGSLQKR |
| Proinsulin C-peptide human | EAEDLQVGQVELGGGPGAGSLQPLALEGSLQ |
| Prolactin Releasing Peptide (12-31), human | TPDINPAWYASRGIRPVGRF-NH2 |
| Prolactin Releasing Peptide (1-31), human | SRTHRHSMEIRTPDINPAWYASRGIRPVGRF-NH2 |
| Prolylleucine | Z-Pro-{d-Leu} |
| Protease-Activated Receptor-2 Activating Peptide | SLIGRL-NH2 |
| Protease-Activated Receptor-2, PAR-2 Agonist, amide | SLIGKV-NH2 |
| Protein Kinase C (19-35) Peptide | RFARKGALRQKNVHEVK |
| Protein Kinase C (gamma) Peptide | NYPLELYERVRTGC |
| Protein Kinase C 19-31 | RFARKGALRQKNV |
| Protein Kinase C 19-36 | RFARKGALRQKNVHEVKN |
| Protein Kinase C Peptide Substrate | ERMRPRKRQGSVRRRV |
| Protirelin Acetate | {pGlu}-HP-NH2 |
| PrP 106-126 | KTNMKHMAGAAAAGAVVGGLG |
| PSA1 141-150 | FLTPKKLQCV |
| PTD-p65-P1 Peptide | DRQIKIWFQNRRMKWKKQLRRPSDRELSE |
| PUMA BH3 | EEQWAREIGAQLRRMADDLNAQYER |
| QKRPSQRSKYL | QKRPSQRSKYL |
| QL9 | QLSPFPFDL |
| R15K, HIV-1 Inhibitory Peptide | RIQRGPGRAFVTIGK |
| Rabies Virus Glycoprotein (RVG29) | YTIWMPENPRPGTPCDIFTNSRGKRASNG |
| Rat CGRP-(8-37) | VTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2 |
| RC-160 (Vapreotide) | fCYwKVCW-NH2 (C2&C7 bridge) |
| RC-3095 | XQWAVGHLL-NH2 |
| RC-3095 (TFA) | Xaa-Gln-Trp-Ala-Val-Gly-His-Leu-Leu-NH2 |
| ReACp53 | HRRRRRRRRRRPILTRITLE-OH |
| Renin Substrate Tetradecapeptide, rat | DRVYIHPFHLLYYS |
| RGD | RGD |
| RGD peptide GRGDNP | GRGDNP |
| RGDS | Arg-Gly-Glu-Ser(TFA) |
| rGHRH(1-29)NH2 | HADAIFTSSYRRILGQLYARKLLHEIMNR |
| Rhodopsin Epitope Tag | TETSQVAPA |
| Risuteganib | GRG-{Cya}-TP |
| RNAIII-inhibiting peptide(TFA) | YSPWTNF |
| RREEETEEE | RREEETEEE |
| RR-SRC | RRLIEDAEYAARG |
| Rusalatide acetate | AGYKPDEGKR GDACEGDSGG PFV-NH2 |
| S Tag Peptide | KETAAAKFERQHMDS |
| S6-1 | RRLSSLRA |
| S961 | GSLDESFYDWFERQLGGGSGGSSLEEEWAQIQCEVWGRGCPSY (Disulfide bridge: Cys33-Cys40) |
| Sakamototide substrate peptide TFA | ALNRTSSDSALHRRR |
| SAMS | HMRSAMSGLHLVKRR-NH2 |
| Scrambled TRAP Fragment | FSLLRN-NH2 |
| Scyliorhinin II | SPSNSKCPDGPDCFVGLM-NH2 |
| SDV-Exendin-3/4 | SDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS |
| SEB Domain 144-153 | KKKVTAQELD |
| Secretin (5-27), porcine | TFTSELSRLRDSARLQRLLQGLV-NH2 |
| Secretin, canine | HSDGTFTSELSRLRESARLQRLLQGLV-NH2 |
| Secretin, human | HSDGTFTSELSRLREGARLQRLLQGLV-NH2 |
| Secretin, porcine | HSDGTFTSELSRLRDSARLQRLLQGLV-NH2 |
| Secretin, rat | HSDGTFTSELSRLQDSARLQRLLQGLV-NH2 |
| Secretoneurin, rat | TNEIVEEQYTPQSLATLESVFQELGKLTGPSNQ |
| Selank | TKPRPGP |
| Ser25] Protein Kinase C (19-31) | RFARKGSLRQKNV |
| sgp91 ds-tat Peptide 2, scrambled | RKKRRQRRRCLRITRQSR-NH2 |
| Sincalide | D-{SO3H-Tyr}-MGWMDF-NH2 |
| SIYRY | SIYRYYGL |
| SLLK, Control Peptide for TSP1 Inhibitor | SLLK-NH2 |
| Small Cardioactive Peptide B SCPB | MNYLAFPRM-NH2 |
| SMCY (950-960) (human) | SPSVDKARAEL |
| Smcy HY Peptide 738-746 | KCSRNRQYL |
| SNAP-25 187-203 | Ac-SNKTRIDEANQRATKML-NH2 |
| Somatostatin 28 (1-14) | SANSNPAMAPRERK |
| Somatostatin1-14 | AGCKNFFWKTFTSC (C3&C14 bridge) |
| Somatostatin-25 | SNPAMAPRERKAGCKNFFWKTFTSC (Disulfide bridge: Cys14-Cys25) |
| Somatostatin-28 1-12 | SANSNPAMAPRE |
| SPACE peptide | ACTGSTQHQCG (Disulfide bridge: Cys2-Cys10) |
| Speract | GFDLNGGGVG |
| Sphistin Synthetic Peptide(12-38,Fitc in N-Terminal-Fluorescently Labeled Peptide) | FITC-KAKAKAVSRSARAGLQFPVGRIHRHLK |
| ß-Amyloid (25-35) | NH2-GSNKGAIIGLM-COOH |
| Substance P (1-9) | RPKPQQFFG |
| Substance P (7-11) | FFGLM-NH2 |
| Substance P 1-7 | RPKPQQF |
| Substance P, Free Acid | RPKPQQFFGLM |
| Substrate for Tyrosine Protein Kinase | RRLIEDNEYTARG |
| Suc-Leu-Leu-Val-Tyr-AMC | Suc-Leu-Leu-Val-Tyr-AMC |
| Super-TDU (1-31) TFA | SVDDHFAKSLGDTWLQIGGSGNPKTANVPQT |
| Super-TDU (TFA) | SVDDHFAKSLGDTWLQIGGSGNPKTANVPQTVPMRLRKLPDSFFKPPE |
| SV40 large T antigen NLS | CGGGPKKKRKVED |
| SV40 T-Ag-derived NLS peptide | PKKKRKVEDPYC |
| Syntide 2 | PLARTLSVAGLPGKK |
| SYSMEHFRWGKPS | SYSMEHFRWGKPS |
| Systemin | AVQSKPPSKRDPPKMQTD |
| T7 Tag Peptide | MASMTGGQQMG |
| TAK-448 acetate | Ac-Y-{Hyp}-NTFGLRW-NH2 |
| TAT | YGRKKRRQRRR-NH2 |
| TAT 2-4 | YGRKKRRQRRRGYGRKKRRQRRRG |
| TAT 48-57 | GRKKRRQRRR |
| TAT peptide | GRKKRRQRRRPQ |
| TB500 | Ac-LKKTETQ |
| Tetanus toxin 830-843 | QYIKANSKFIGITE |
| TFLLR-NH2(TFA) | TFLLR-NH2 |
| Thioredoxin reductase peptide | WGLGGTCVNVGCIPK |
| Thrombin Receptor Activator for Peptide 5 TRAP-5 | SFLLR |
| Thymalfasin | Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN |
| Thymopentin | RKDVY |
| Thymopoietin II (32-34) | RKD |
| Thymopoietin II (32-35) | RKDV |
| Thyrotropin-Releasing Hormone (TRH), Free Acid | {pGlu}-HP |
| TIP 39, Tuberoinfundibular Neuropeptide | SLALADDAAFRERARLLAALERRHWLNSYMHKLLVLDAP |
| Tirzepatide | Y-{Aib}-EGTFTSDYSI-{Aib}-LDKIAQ-{diacid-gamma-Glu-(AEEA)2-Lys}-AFVQWLIAGGPSSGAPPPS-NH2 |
| TLQP-30 | TLQPPASSRRRHFHHALPPARHHPDLEAQA |
| TNF-α (10-36), human | DKPVAHVVANPQAEGQLQWLNRRANAL |
| TNF-α (31-45), human TFA | RRANALLANGVELRD |
| TNF-α (46-65), human | NQLVVPSEGLYLIYSQVLFK |
| Tos-Gly-Pro-Arg-ANBA-IPA acetate | Tos-GPR-ANBA-IPA |
| TP508 | AGYKPDEGKRGDACEGDSGGPFV |
| Transportan | GWTLNSAGYLLGKINLKALAALAKKIL-NH2 |
| Trp-Asn-Arg-Gln-Leu-Tyr-Pro-Glu-Trp-Thr-Glu-Ala-Gln-Arg-Leu-Asp | WNRQLYPEWTEAQRLD |
| Tuftsin | TKPR |
| Tyr-Ile-Tyr-Gly-Ser-Phe-Lys | YIYGSFK |
| Tyrosinase (192-200), human mouse | SEIWRDIDF |
| Tyrosinase (206-214), human | AFLPWHRLF |
| Tyrosine Protein Kinase JAK 2 Phospho-Tyr8, 9 | VLPQDKE-{pTyr}{pTyr}-KVKEPGE |
| Tyr-Somatostatin-14 | YAGCKNFFWKTFTSC (Disulfide bridge: Cys4-Cys15) |
| Urechistachykinin I | LRQSQFVGSR-NH2 |
| Urechistachykinin II | AAGMGFFGAR-NH2 |
| Urocortin II, human | IVLSLDVPIGLLQILLEQARARAAREQATTNARILARVGHC-NH2 |
| Urocortin III, human | FTLSLDVPTNIMNLLFNIAKAKNLRAQAAANAHLMAQI-NH2 |
| Urocortin III, mouse | FTLSLDVPTNIMNILFNIDKAKNLRAKAAANAQLMAQI-NH2 |
| Urocortin III, mouse, free acid | FTLSLDVPTNIMNILFNIDKAKNLRAKAAANAQLMAQI |
| Urocortin, human | DNPSLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV-NH2 |
| Urocortin, rat | DDPPLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV-NH2 |
| Urotensin I | NDDPPISIDLTFHLLRNMIEMARIENEREQAGLNRKYLDEV-NH2 |
| Urotensin II (114-124), human | ETPDCFWKYCV (Disulfide bridge: Cys5-Cys7) |
| Urotensin II, mouse | {pGlu}-HGAAPECFWKYCI (Disulfide bridge: Cys8-Cys13) |
| Uty HY Peptide 246-254 | WMHHNMDLI |
| V5 Epitope Tag Peptide Trifluoroacetate | GKPIPNPLLGLDST |
| Vasonatrin Peptide VNP | GLSKGCFGLKLDRIGSMSGLGCNSFRY (Disulfide bridge: Cys6-Cys22) |
| VIP(6-28)(human, rat, porcine, bovine) | FTDNYTRLRKQMAVKKYLNSILN-NH2 |
| VIP, guinea pig | HSDALFTDTYTRLRKQMAMKKYLNSVLN-NH2 |
| VIP, human, porcine, rat, ovine | HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2 |
| VIR-165 | LEAIPCSIPPCFAFNKPFVF (Disulfide bridge: Cys6-Cys11) |
| VSV-G Peptide | YTDIEMNRLGK |
| WKYMVM | WKYMV-{d-Met} |
| WKYMVM TFA | WKYMVM-NH2 |
| Xenin | MLTKFETKSARVKGLSFHPKRPWIL |
| Xenopsin | {Glp}-GKRPWIL |
| X-press Tag Peptide | DLYDDDDK |
| YRGDS Fibronectin Fragment | YRGDS |
| Z-Gly-Gly-Arg-AMC | ZGGR-AMC |
| Z-VRPR-FMK (TFA) | Z-VRPR-FMK |
| α2β1 Integrin Ligand Peptide | DGEA |
| α-Bag Cell Peptide (1-7) | APRLRFY |
| α-Bag Cell Peptide (1-8) | APRLRFYS |
| α-Bag Cell Peptide (1-9) | APRLRFYSL |
| α-Casein 90-95 | RYLGYL |
| α-Factor Mating Pheromone, yeast | WHWLQLKPGQPMY |
| α-Melanocyte-Stimulating Hormone (MSH), amide(α-MSH) | Ac-SYSMEHFRWGKPV-NH2 |
| α-MSH | Ac-SYSMEHFRWGKPV-CONH2 |
| α-Neoendorphin 1-8 | YGGFLRKY |
| β-Amyloid (1-10) | DAEFRHDSGY |
| β-Amyloid (1-11) | DAEFRHDSGYE |
| β-Amyloid (1-12) | DAEFRHDSGYEV |
| β-Amyloid (1-13) | DAEFRHDSGYEVH |
| β-Amyloid (1-14) | DAEFRHDSGYEVHH |
| β-Amyloid (1-18) | DAEFRHDSGYEVHHQKLV |
| β-Amyloid (1-20) | DAEFRHDSGYEVHHQKLVFF |
| β-Amyloid (1-28) | DAEFRHDSGYEVHHQKLVFFAEDVGSNK |
| β-Amyloid (1-40) | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV |
| β-Amyloid (1-42), human | DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| β-Amyloid (1-42), rat | DAEFGHDSGFEVRHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| β-Amyloid (1-9) | DAEFRHDSG |
| β-Amyloid (25-35) | GSNKGAIIGLM |
| β-Amyloid 12-20 | VHHQKLVFF |
| β-Amyloid 4-10 | FRHDSGY |
| β-Bag Cell Factor | RLRFH |
| β-Casomorphin (1-3), amide | YPF-NH2 |
| β-Casomorphin (1-5), amide, bovine | Y-{d-Ala}-FPM-NH2 |
| β-Casomorphin (1-5), bovine | YPFPG |
| β-Casomorphin (1-6), bovine | YPFPGP |
| β-Casomorphin, bovine | YPFPGPI |
| β-Casomorphin, human | YPFVEPI |
| β-catenin peptide | RTYTYEKL |
| β-CGRP, human TFA | ACNTATCVTHRLAGLLSRSGGMVKSNFVPTNVGSKAF-NH2(Disulfide bridge: Cys2-Cys7) |
| β-Endorphin, equine | YGGFMSSEKSQTPLVTLFKNAIIKNAHKKGQ |
| β-Melanocyte Stimulating Hormone (MSH), human TFA | AEKKDEGPYRMEHFRWGSPPKD |
| γ-1-Melanocyte Stimulating Hormone (MSH), amide | YVMGHFRWDRF-NH2 |
| γ-2-MSH (41-58), amide | YVMGHFRWDRFG-NH2 |
| γ-Bag Cell Factor | RLRFD |
| γ-Glu-Phe | γ-Glu-Phe |